Vimta Labs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
VIMTALABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.5 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vimta Labs posted strong Q1 FY26 results with revenue from operations rising about 30% year-on-year to Rs 975.64 million (vs Rs 748.76 million in Q1 FY25). Total income grew to Rs 993.13 million. Profit after tax from continuing operations jumped roughly 36% to Rs 188.94 million (vs Rs 139.05 million), while basic EPS stood at Rs 4.25 (adjusted for the recent 1:1 bonus issue). The statutory auditor issued an unmodified limited review report with no qualifications. Separately, the Board approved the change of cost auditor M/s Lavanya and Associates from a proprietorship to an LLP for FY25 and FY26, and granted 42,589 stock options to employees under the ESOP 2021 plan.
Strong double-digit revenue and profit growth on a like-for-like continuing-operations basis is a clear positive for shareholders, supported by a clean auditor report. Per-share figures have been adjusted for the recent 1:1 bonus issue, so headline EPS comparisons should account for the doubled share count. Net impact is constructive on earnings momentum.